Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
Finch Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Finch Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Finch Therapeutics Announces Takeda to Accelerate Leadership Role in FIN-524 Ulcerative Colitis Development Program
Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates
Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
Finch Therapeutics Appoints Susan E. Graf to Board of Directors
Finch Therapeutics to Participate in the Jefferies Microbiome-Based Therapeutics Summit
